Outpatient Cancer Care
Comprehensive portfolio of oral cancer medicines including chemotherapy tablets, hormone therapies, and kinase inhibitors for convenient outpatient treatment.
Explore our portfolio of 6 high-quality oncology products designed to meet the highest international standards.
Oral fluoropyrimidine chemotherapy. Prodrug converted to active 5-FU in tumor tissue for colorectal and breast cancer.
Indications:
Alkylating agent for brain tumors and melanoma. Crosses blood-brain barrier for CNS malignancy treatment.
Indications:
First-generation tyrosine kinase inhibitor. Revolutionary targeted therapy for CML and GIST.
Indications:
EGFR tyrosine kinase inhibitor for lung cancer with specific genetic mutations.
Indications:
Aromatase inhibitor for hormone-sensitive breast cancer in postmenopausal women.
Indications:
Non-steroidal aromatase inhibitor for postmenopausal hormone-positive breast cancer.
Indications:
Our commitment to quality is backed by international certifications and regulatory compliance across multiple markets.
Available
Products manufactured at WHO Good Manufacturing Practice certified facilities
36AARCP2455C1Z8
Registered for Goods and Services Tax in India
UDYAM-TS-02-0354028
Micro, Small and Medium Enterprises registration
Just say available
Central and state drug regulatory approvals in India
International regulatory submissions for major markets
Interested in our oncology products? Contact us for product catalogs, regulatory documentation, or partnership opportunities.
Oncology product development and registration
Technology transfer and formulation development
Contract manufacturing partnerships with WHO-GMP facilities
Regulatory dossier support for FDA, EMA, TGA, COFEPRIS and Asian markets
Licensing and distribution partnerships globally
Contact our team for detailed product specifications, regulatory documentation, or partnership opportunities.